NVIDIA: GTC skepticism, earnings hype, China risks/SMCI CNode-X and verifiable bookings
Key Questions
What is the Wall Street sentiment around NVIDIA's GTC event?
Wall Street shows skepticism toward GTC announcements like Vera CPU, NemoClaw, $1T backlog, and $1T revenue predictions despite Zacks #1 bull rating at 23.7x P/E. Focus is on shipments, bookings, and TCO versus alternatives. Buyside watches earnings hype amid risks.
What are the China-related risks for NVIDIA?
NVIDIA faces -51% smuggling issues with SMCI CNode-X and Blackwell in China, alongside broader China risks. Micron supply is not expected until after 2026. These factors contribute to GTC skepticism.
What investments is NVIDIA making in AI startups?
NVIDIA is leading Sarvam AI's $250M round at $1.5B valuation alongside Accel and HCLTech. It's also backing Reflection AI, which eyes a $25B valuation with a $2.5B raise. NVDA leads these high-profile deals.
What are the key NVIDIA metrics buyside investors are tracking?
Buyside focuses on shipments, bookings, and TCO comparisons versus alternatives. Earnings hype surrounds GTC despite skepticism. Verifiable bookings and backlog claims are under scrutiny.
How does NVIDIA's leadership in AI investments look?
NVIDIA leads Sarvam's $250M raise at $1.5B and backs Reflection AI's potential $2.5B round at $25B valuation. These moves underscore NVDA's role in AI ecosystem growth. They occur amid GTC and earnings focus.
GTC Vera CPU/NemoClaw/$1T backlog/$1T rev pred face Wall St skepticism but Zacks #1 bull (P/E 23.7x); SMCI CNode-X/Blackwell/-51% smuggling; Micron >2026 supply; NVDA leads Sarvam $250M/$1.5B; Reflection AI $25B val/$2.5B raise. Buyside: shipments/bookings/TCO vs alts.